rxstat › Classes › Ocular Vascular Disorder Agents

Ocular Vascular Disorder Agents: shortage status in Canada

2 of the 3 ocular vascular disorder agents rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageVerteporfin1 of 1 reported products affected · est. return Dec 31, 2026Partial shortageRanibizumab1 of 1 reported products affected · est. return Jun 30, 2027No current shortageAflibercept

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.